Keymed Biosciences Inc. has successfully completed the placement of existing shares and a top-up subscription of new shares under its general mandate. This move was coordinated by a sole overall coordinator, global coordinator, and lead bookrunner, with joint bookrunners involved in the process. The placement and subscription aim to enhance the company's capital structure and support its future growth initiatives. The announcement emphasizes that the offering is not intended to solicit any offers or invitations to acquire, purchase, or subscribe to any securities.